Page last updated: 2024-09-04

cvt 124 and Heart Failure

cvt 124 has been researched along with Heart Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gottlieb, SS1
Dohadwala, MM; Givertz, MM1
Miracle, C; Thomson, S; Vallon, V1
Beckman, E; Bennett, D; Cines, M; Fisher, ML; Freudenberger, R; Gladwell, T; Gottlieb, SS; Liittschwager, EB; Marshall, J; Skettino, SL; Wolff, A1
Abraham, WT; Beckman, E; Bennett, D; Bourge, R; Brater, DC; Dyer, F; Goldman, S; Gomez, M; Gottlieb, SS; Havranek, E; Thomas, I; Ticho, B1
Crawford, FA; Escobar, GP; Hendrick, JW; Lucas, DG; Mukherjee, R; Sample, JA; Smits, GJ; Spinale, FG1

Reviews

3 review(s) available for cvt 124 and Heart Failure

ArticleYear
Adenosine A1 antagonists and the cardiorenal syndrome.
    Current heart failure reports, 2008, Volume: 5, Issue:2

    Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Prognosis; Randomized Controlled Trials as Topic; Receptor, Adenosine A1; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Xanthines

2008
Role of adenosine antagonism in the cardiorenal syndrome.
    Cardiovascular therapeutics, 2008,Winter, Volume: 26, Issue:4

    Topics: Adenosine A1 Receptor Antagonists; Animals; Heart Failure; Hospital Mortality; Humans; Kidney Failure, Chronic; Registries; Syndrome; Xanthines

2008
Adenosine and kidney function: potential implications in patients with heart failure.
    European journal of heart failure, 2008, Volume: 10, Issue:2

    Topics: Adenosine; Animals; Heart Failure; Humans; Kidney; Kidney Tubules, Collecting; Kidney Tubules, Proximal; Receptors, Purinergic P1; Reperfusion Injury; Vasoconstriction; Vasopressins; Xanthines

2008

Trials

2 trial(s) available for cvt 124 and Heart Failure

ArticleYear
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
    Journal of the American College of Cardiology, 2000, Volume: 35, Issue:1

    Topics: Adult; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged; Natriuresis; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Water-Electrolyte Balance; Xanthines

2000
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
    Circulation, 2002, Mar-19, Volume: 105, Issue:11

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diuresis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Purinergic P1 Receptor Antagonists; Sodium; Urinalysis; Xanthines

2002

Other Studies

1 other study(ies) available for cvt 124 and Heart Failure

ArticleYear
Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure.
    Journal of the American College of Surgeons, 2002, Volume: 194, Issue:5

    Topics: Animals; Heart Failure; Hemodynamics; Kidney; Male; Purinergic P1 Receptor Antagonists; Swine; Xanthines

2002